Abstract
Background: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating and poorly understood condition, often underrepresented in healthcare planning and resource allocation. Integrated care models for ME/CFS patients are hindered by the lack of reliable and actionable key performance indicators (KPIs) that measure both clinical outcomes and the effectiveness of comprehensive, multi-disciplinary care strategies. The project lzp-2024/1-0343 “Digital monitoring for integrated progression assessment of myalgic encephalomyelitis/chronic fatigue syndrome” seeks to establish robust KPIs tailored for ME/CFS, enhancing patient management and advancing holistic, patient-centred care.
Approach: Our multi-phase approach incorporates extensive stakeholder engagement to develop effective KPIs for integrated care of ME/CFS patients. We collaborated with healthcare providers, patient advocacy groups, data scientists, and policymakers to identify and define key performance metrics. Personal and Public Involvement (PPI) was integral to our methodology, with ME/CFS patients contributing insights on meaningful outcomes and care priorities. The KPIs were designed to reflect clinical improvement, patient quality of life, healthcare access, and system-level efficiency. Additionally, data-driven tools, including digital phenotyping and patient-reported outcome measures (PROMs), were leveraged to ensure that the KPIs are patient-centric and evidence-based.
Results: Our comprehensive set of KPIs includes measures of symptom severity, functional capacity, patient satisfaction, and healthcare utilization. Pilot testing demonstrated that these indicators effectively capture the complexity of ME/CFS, facilitating early identification of disease progression and treatment responsiveness. Initial findings also reveal that using these KPIs can streamline care pathways, optimize resource allocation, and improve interdisciplinary communication. The alignment of digital monitoring metrics with traditional clinical indicators further supports the validity and reliability of our proposed framework.
Implications: Establishing well-defined KPIs for ME/CFS integrated care provides a blueprint for improving patient outcomes and enhancing service delivery. Our results emphasize the need for adaptive, data-driven metrics that inform clinical decision-making and policy development. Future work will focus on validating these KPIs across diverse healthcare settings and incorporating them into clinical guidelines. We encourage healthcare leaders and policymakers to consider the scalability of our approach, contributing to a more coordinated and efficient care model for chronic and complex conditions like ME/CFS.